3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
66
Lymphoma, Follicular
21
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Mantle-Cell
10
Lymphoma
10
Recurrence
7
Lymphoma, B-Cell, Marginal Zone
7
Neoplasms, Plasma Cell
6
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Smoldering Multiple Myeloma
3
Neoplasms
3
Neuroblastoma
2
Neoplasm, Residual
2
Myelodysplastic Syndromes
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Hematologic Diseases
2
Burkitt Lymphoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Interventions
Vincristine
7
Cyclophosphamide
7
Methotrexate
6
Dexamethasone
6
Cytarabine
6
merphos
5
Mercaptopurine
5
Doxorubicin
5
pegaspargase
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
blinatumomab
4
azathiopurine
4
auricularum
4
Prednisone
4
Leucovorin
4
Inotuzumab Ozogamicin
4
Calcium Dobesilate
4
prednylidene
3
deltacortene
3
Thioguanine
3
Specimen Handling
3
N,N-dicyclohexyl-isoborneol-10-sulfonamide
3
Methylprednisolone
3
Asparaginase
3
calaspargase pegol
2
asparaginase erwinia chrysanthemi recombinant
2
Spinal Puncture
2
Rituximab
2
Radiotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
×
Lenalidomide
×
90 days
×
Clear all
No trials found.